Skip to main content
Equibles

Arax Advisory Partners

Position in CLDI — Calidi Biotherapeutics, Inc.

CIK 1586767 DENVER, CO
Back to CLDI Full portfolio

Position in CLDI

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$6,348
-$2,577 QoQ
Shares Held
2,334
0.0% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 23 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in CLDI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Arax Advisory Partners holds $59,760,217 across 287 Biotechnology names. CLDI ranks #198 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 118,402 $13,422,050
2 REGN
Regeneron Pharmaceuticals, Inc.
 9,563 $5,962,913
3 ALNY
Alnylam Pharmaceuticals, Inc.
 13,844 $4,167,459
4 EXEL
Exelixis, Inc.
 70,160 $3,817,405
5 VKTX
Viking Therapeutics, Inc.
 66,469 $2,592,955
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,662 $2,315,755
7 MESO
Mesoblast Ltd
 168,022 $2,273,337
8 FTRE
Fortrea Holdings Inc.
 88,116 $1,533,218

All Filings in CLDI

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,348 37,345
2026-03-31 $8,925 37,345